| Trial ID: | L5476 |
| Source ID: | NCT00857870
|
| Associated Drug: |
Metformin
|
| Title: |
Insulin Glargine First Line vs Metformin in Type 2 Diabetic Subjects
|
| Acronym: |
GLORY
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Metformin|DRUG: Insulin glargine
|
| Outcome Measures: |
Primary: Area under the curve (AUC) after a testmeal measured CGM., baseline and visit 8 | Secondary: HbA1C, glycemic variability, glycemic load, insulin secretion after testmeal, free fatty acids, biomarkers of low grade inflammation, endothelial dysfunction., baseline and visit 8
|
| Sponsor/Collaborators: |
Sponsor: GWT-TUD GmbH
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
96
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-03
|
| Completion Date: |
2011-12
|
| Results First Posted: |
|
| Last Update Posted: |
2012-01-11
|
| Locations: |
GWT -TUD, Center for Clinical Studies, Dresden, 01307, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00857870
|
